Skip to Main Content

Author Details

Carolyn A Goard
Princess Margaret Cancer Centre, Ontario Cancer Institute
2007
14
12
PMIDPaper TitleJournal TitlePublished Year
25631767AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress.Blood2015
26353928Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.Oncotarget2015
23770858Mitochondrial matrix proteases as novel therapeutic targets in malignancy.Oncogene2014
25285531A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia.PLoS One2014
24871339A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activity.PLoS One2014
24691136Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.PLoS One2014
24337703Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells.Breast Cancer Res Treat2014
24273151Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.Am J Hematol2014
23515850An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies.Core Evid2013
20298590Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance.BMC Cancer2010
21351272Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.Int J Cancer2010
16927403The apoptosis modulator and tumour suppressor protein RBM5 is a phosphoprotein.Cell Biochem Funct2007
17131366Expression of RBM5-related factors in primary breast tissue.J Cell Biochem2007
19383304A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus.Mol Oncol2007
  • 1 - 14 of 14

Recommended Authors

Joseph Longo
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 2015
Number of shared co-authors 7
Hazel X Ang
Duke University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Evangelos Pazarentzos
University of California san francisco
Career Start Year 2011
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
In??s A Barbosa
Research Institute of Molecular Pathology
Career Start Year 2007
Number of shared co-authors 0
Jaclyn LoPiccolo
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 0
Ahmed Aman
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2007
Number of shared co-authors 11
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Chandra C Ghosh
The Wistar Institute
Career Start Year 1999
Number of shared co-authors 0
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year 1998
Number of shared co-authors 0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Ricky W Johnstone
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 0
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 4
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
David J McConkey
Johns Hopkins School of Medicine
Career Start Year 1986
Number of shared co-authors 2
Chiara Riganti
University of Turin
Career Start Year 1985
Number of shared co-authors 2
Scott H Kaufmann
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 3
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 0

Collaborators

Aaron D Schimmer
Princess Margaret Cancer Centre
Co-authored papers 7
Linda Z Penn
University of Toronto
Co-authored papers 5
Rose Hurren
Princess Margaret Cancer Centre
Co-authored papers 4
Marcela Gronda
Princess Margaret Cancer Centre
Co-authored papers 3
James W Clendening
The Ontario Cancer Institute, Princess Margaret Hospital, University of Toronto
Co-authored papers 3
Peter J Mullen
University of St Andrews
Co-authored papers 3
Anna Martirosyan
West Virginia University
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Amanda R Wasylishen
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Jason Moffat
University of Toronto
Co-authored papers 1
John E Dick
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Co-authored papers 1
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers 1
Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Co-authored papers 1
Sirano Dhe-Paganon
Dana-Farber Cancer Institute
Co-authored papers 1
Balpreet Vinepal
Co-authored papers 1
Kevin R Brown
College Street, University of Toronto
Co-authored papers 1
Daniel J DeAngelo
Dana-Farber Cancer Institute
Co-authored papers 1
Syed Haider
Institute of Cancer Research
Co-authored papers 1
Gautam Borthakur
MD Anderson Cancer Center
Co-authored papers 1
Bruno C Medeiros
AbbVie Inc.
Co-authored papers 1
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers 1
Suzanne Trudel
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Traver Hart
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Michelle Chan-Seng-Yue
Princess Margaret Cancer Centre
Co-authored papers 1
Scott J Weir
University of Kansas Medical Center
Co-authored papers 1
Manpreet Kalkat
Van Andel Institute
Co-authored papers 1
Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 1
Richard Lehner
University of Alberta
Co-authored papers 1
Marinella Gebbia
University of Toronto
Co-authored papers 1
Release 1.2